← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2015Last known activity
May 10, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03428230Overall official - principal investigatorPhase 2May 10, 2018
- NCT02654860Overall official - principal investigatorPhase 2Feb 1, 2016
- NCT02385097Overall official - principal investigatorPhase 3Mar 1, 2015
Details
- Last known activity
- May 10, 2018